Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Network.
Press releases published on July 23, 2025
Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
GlobeNewswire
·
July 23, 2025
Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer
GlobeNewswire
·
July 23, 2025
SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics, a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases, today announced the appointment of Tony Estrada, Ph. …
Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody
GlobeNewswire
·
July 23, 2025
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first data readout expected in mid-2026 WIN378 has the potential to be the first-to-market long-acting, anti-TSLP antibody with twice-yearly …
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 43rd Annual Meeting July 29-August 2
GlobeNewswire
·
July 23, 2025
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from its clinical studies of …
IperionX – June 2025 Quarterly Report
GlobeNewswire
·
July 23, 2025
CHARLOTTE, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending June 30, 2025. Key highlights during and subsequent to the end of the quarter include: …
Maxus Mining Expands Land Holdings at the Hurley Antimony Project in British Columbia, Canada
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce that the Company has expanded its land holdings by approximately 2,431 hectares at the Hurley …
Aventis Energy Announces Results of High-Resolution TDEM Survey at the Corvo Uranium Project in Northern Saskatchewan
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Aventis Energy (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to provide a summary of results from an airborne Time Domain Electromagnetic (“TDEM”) survey (the “ …
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
GlobeNewswire
·
July 23, 2025
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that three …
NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada
GlobeNewswire
·
July 23, 2025
Vancouver, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce extremely positive antimony (“Antimony”, “Sb”) metallurgical testwork results at its …
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
GlobeNewswire
·
July 23, 2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in …
BitFuFuPool Surpasses 20 EH/s, Ranks Among Top Global Bitcoin Mining Pools
GlobeNewswire
·
July 23, 2025
SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that its private-label Bitcoin mining pool, BitFuFuPool, has surpassed 20 …
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib
GlobeNewswire
·
July 23, 2025
Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and immunotherapy but have not been previously …
Luckin Coffee to Announce Second Quarter 2025 Financial Results on July 30, 2025
GlobeNewswire
·
July 23, 2025
BEIJING, July 23, 2025 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its second quarter 2025 financial results before the U.S. market opens on Wednesday, July 30, 2025. The Company will hold a …
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
GlobeNewswire
·
July 23, 2025
- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function CASR variants was ~3.7 per 100,000, closely aligned to previously published estimates1 (3.9 per 100,000), which equates to …
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 23, 2025
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery) Study Group. …
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire
·
July 23, 2025
WATERTOWN, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three clinical-stage programs, today …
La Production de Silice Pyrogénée à L’échelle Pilote d’HPQ Approche la Viabilité Commerciale
GlobeNewswire
·
July 23, 2025
MONTRÉAL, 23 juill. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique axée sur l’innovation dans le développement de matériaux avancés et de procédés critiques, a le …
HPQ’s Pilot-Scale Fumed Silica Production Nears Commercial Viability
GlobeNewswire
·
July 23, 2025
MONTREAL, July 23, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to update shareholders on …
WEBUY GLOBAL LTD. Partners with Victory Securities to Pioneer Stablecoin Adoption
GlobeNewswire
·
July 23, 2025
Singapore, July 23, 2025 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a fast-growing Southeast Asian e-commerce and travel tech company, is pleased to announce its intention to explore further collaboration on stablecoin …
First Atlantic Nickel Unveils Initial Phase 2 Drill Plan Map with Drilling Underway Following Phase 1 Discovery at RPM Zone Confirming First Large-Scale Awaruite in the Atlantic
GlobeNewswire
·
July 23, 2025
GRAND FALLS-WINDSOR, Newfoundland and Labrador, July 23, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce the release of its Initial Phase 2 Drill Plan Map …